Psychometric validation of the Chinese Version of the stimulant relapse risk scale (SRRS) in patients with methamphetamine use disorder.
Instrument
Methamphetamine
Psychometric properties
SRRS
Validity
Journal
Substance abuse treatment, prevention, and policy
ISSN: 1747-597X
Titre abrégé: Subst Abuse Treat Prev Policy
Pays: England
ID NLM: 101258060
Informations de publication
Date de publication:
08 Jul 2024
08 Jul 2024
Historique:
received:
14
12
2023
accepted:
01
07
2024
medline:
9
7
2024
pubmed:
9
7
2024
entrez:
8
7
2024
Statut:
epublish
Résumé
Evaluating the risk of relapse is a pivotal step in the treatment of patients with methamphetamine use disorder (MUD). The 30-item Stimulant Relapse Risk Scale (SRRS) was originally developed in Japan to meet the demand. This study examined the reliability, validity, and factor structure of the Chinese version of the SRRS for patients with MUD. 247 patients with MUD self-rated the Chinese version of the SRRS. Cronbach's alpha coefficients and inter-item correlation analysis were used to assess the internal consistency reliability. Construct validity was determined through confirmatory factor analysis (CFA), and concurrent validity was examined using the visual analogue scale (VAS) for drug craving and the severity of dependence scale (SDS). We followed the participants for 1 year and assessed the predictive validity based on the correlation of the scores of the Chinese version of the SRRS with the relapse rate within 3, 6, and 12 months of follow-up. CFA revealed satisfactory model fit estimates for the 22-item Chinese version of the SRRS that consisted of four subscales. The four-factored 22-item Chinese version of the SRRS had adequate internal consistency with Cronbach's alphas ranging from 0.76 to 0.92. The 22-item Chinese version of the SRRS scores were significantly correlated with the VAS and SDS scores as well as the relapse rate within 3, 6, and 12 months, indicating good concurrent and predictive validity of this scale. The receiver operating characteristic curve revealed a cutoff score of 40 could discriminate between participants with (SDS score ≥ 4) and without (SDS score < 4) methamphetamine dependence (area under the curve = 0.71, p < 0.01). The 22-item Chinese version of the SRRS that consists of four subscales is a valid and reliable instrument to assess the relapse risk in patients with MUD.
Sections du résumé
BACKGROUND
BACKGROUND
Evaluating the risk of relapse is a pivotal step in the treatment of patients with methamphetamine use disorder (MUD). The 30-item Stimulant Relapse Risk Scale (SRRS) was originally developed in Japan to meet the demand. This study examined the reliability, validity, and factor structure of the Chinese version of the SRRS for patients with MUD.
METHODS
METHODS
247 patients with MUD self-rated the Chinese version of the SRRS. Cronbach's alpha coefficients and inter-item correlation analysis were used to assess the internal consistency reliability. Construct validity was determined through confirmatory factor analysis (CFA), and concurrent validity was examined using the visual analogue scale (VAS) for drug craving and the severity of dependence scale (SDS). We followed the participants for 1 year and assessed the predictive validity based on the correlation of the scores of the Chinese version of the SRRS with the relapse rate within 3, 6, and 12 months of follow-up.
RESULTS
RESULTS
CFA revealed satisfactory model fit estimates for the 22-item Chinese version of the SRRS that consisted of four subscales. The four-factored 22-item Chinese version of the SRRS had adequate internal consistency with Cronbach's alphas ranging from 0.76 to 0.92. The 22-item Chinese version of the SRRS scores were significantly correlated with the VAS and SDS scores as well as the relapse rate within 3, 6, and 12 months, indicating good concurrent and predictive validity of this scale. The receiver operating characteristic curve revealed a cutoff score of 40 could discriminate between participants with (SDS score ≥ 4) and without (SDS score < 4) methamphetamine dependence (area under the curve = 0.71, p < 0.01).
CONCLUSIONS
CONCLUSIONS
The 22-item Chinese version of the SRRS that consists of four subscales is a valid and reliable instrument to assess the relapse risk in patients with MUD.
Identifiants
pubmed: 38978076
doi: 10.1186/s13011-024-00616-8
pii: 10.1186/s13011-024-00616-8
doi:
Substances chimiques
Methamphetamine
44RAL3456C
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
34Subventions
Organisme : National Science and Technology Council
ID : 109-2314-B-532-0041 and 110-2314-B-532-005-MY3
Organisme : National Science and Technology Council
ID : 110-2314-B-715-013
Organisme : Taipei City Government
ID : TPECH 11001-62-003 and 11101-62-029
Organisme : Taipei City Hospital
ID : TPCH 110-61 and 111-56
Organisme : MacKay Medical College
ID : MMC-RD-110-1B-P011 and MMC-RD-111-1H-P007
Informations de copyright
© 2024. The Author(s).
Références
United Nations Office on Drugs and Crime. World drug report 2022: Global overview of drug demand and drug supply 2022 [ https://www.unodc.org/unodc/en/data-and-analysis/wdr-2022_booklet-2.html
Rawson RA. Current research on the epidemiology, medical and psychiatric effects, and treatment of methamphetamine use. J food drug Anal. 2013;21(4):S77–81.
doi: 10.1016/j.jfda.2013.09.039
pubmed: 25214749
Stoneberg DM, Shukla RK, Magness MB. Global methamphetamine trends: an evolving problem. Int Crim Justice Rev. 2018;28(2):136–61.
doi: 10.1177/1057567717730104
United Nations Office on Drugs and Crime. World drug report 2022: drug market trends cocaine amphetamine_type stimulants new psychoactive substances 2022 [Available from: www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html
Lee WC, Chang HM, Huang MC, Pan CH, Su SS, Tsai SY, et al. All-cause and suicide mortality among people with methamphetamine use disorder: a nation‐wide cohort study in Taiwan. Addiction. 2021;116(11):3127–38.
doi: 10.1111/add.15501
pubmed: 33788344
Huang M-C, Yang S-Y, Lin S-K, Chen K-Y, Chen Y-Y, Kuo C-J, et al. Risk of cardiovascular diseases and stroke events in methamphetamine users: a 10-year follow-up study. J Clin Psychiatry. 2016;77(10):11856.
doi: 10.4088/JCP.15m09872
Farrell M, Martin NK, Stockings E, Bórquez A, Cepeda JA, Degenhardt L, et al. Responding to global stimulant use: challenges and opportunities. Lancet. 2019;394(10209):1652–67.
doi: 10.1016/S0140-6736(19)32230-5
pubmed: 31668409
pmcid: 6924572
Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths. United States; 2018. pp. 2011–6.
Brecht M-L, Herbeck D. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend. 2014;139:18–25.
doi: 10.1016/j.drugalcdep.2014.02.702
pubmed: 24685563
pmcid: 4550209
McKetin R, Najman JM, Baker AL, Lubman DI, Dawe S, Ali R, et al. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the M ethamphetamine T reatment E valuation S tudy (MATES). Addiction. 2012;107(11):1998–2008.
doi: 10.1111/j.1360-0443.2012.03933.x
pubmed: 22564065
Bradizza CM, Stasiewicz PR, Paas ND. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clin Psychol Rev. 2006;26(2):162–78.
doi: 10.1016/j.cpr.2005.11.005
pubmed: 16406196
Hartz DT, Frederick-Osborne SL, Galloway GP. Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated-measures, within-subject analysis. Drug Alcohol Depend. 2001;63(3):269–76.
doi: 10.1016/S0376-8716(00)00217-9
pubmed: 11418231
Sinha R. The role of stress in addiction relapse. Curr Psychiatry Rep. 2007;9(5):388–95.
doi: 10.1007/s11920-007-0050-6
pubmed: 17915078
DiClemente CC. Addiction and change: how addictions develop and addicted people recover. Guilford; 2018.
Kaviyani F, Khorrami M, Heydari H, Namvar M. Understanding the laps and relapse process: in-depth interviews with individual who use methamphetamine. Subst Abuse Treat Prev Policy. 2023;18(1):41.
doi: 10.1186/s13011-023-00548-9
pubmed: 37420278
pmcid: 10327377
Kelly JF, Hoeppner BB, Urbanoski KA, Slaymaker V. Predicting relapse among young adults: psychometric validation of the advanced warning of relapse (AWARE) scale. Addict Behav. 2011;36(10):987–93.
doi: 10.1016/j.addbeh.2011.05.013
pubmed: 21700396
pmcid: 3135308
Xu S, Zhang K, Luo T. Development of the risk of Relapse Assessment Scale for methamphetamine abusers in China. Drug Alcohol Depend. 2021;227:108992.
doi: 10.1016/j.drugalcdep.2021.108992
pubmed: 34482042
Heishman SJ, Singleton EG, Liguori A. Marijuana craving questionnaire: development and initial validation of a self-report instrument. Addiction. 2001;96(7):1023–34.
doi: 10.1046/j.1360-0443.2001.967102312.x
pubmed: 11440613
Ogai Y, Haraguchi A, Kondo A, Ishibashi Y, Umeno M, Kikumoto H, et al. Development and validation of the stimulant relapse risk scale for drug abusers in Japan. Drug Alcohol Depend. 2007;88(2–3):174–81.
doi: 10.1016/j.drugalcdep.2006.10.005
pubmed: 17118576
Chen WJ, Wu S-C, Tsay W-I, Chen Y-T, Hsiao P-C, Yu Y-H, et al. Differences in prevalence, socio-behavioral correlates, and psychosocial distress between club drug and hard drug use in Taiwan: results from the 2014 National Survey of Substance Use. Int J Drug Policy. 2017;48:99–107.
doi: 10.1016/j.drugpo.2017.07.003
pubmed: 28810160
Taiwan Food and Drug Administration. National Survey of Substance Use. Taipei, Taiwan: TFDA; 2018.
Browne MW, Cudeck R. Alternative ways of assessing model fit. Sociol Methods Res. 1992;21(2):230–58.
doi: 10.1177/0049124192021002005
Lt H, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Modeling: Multidisciplinary J. 1999;6(1):1–55.
doi: 10.1080/10705519909540118
Chin V, Chen H, Chen H, Lin T-Y, Chou H-H, Laia T-J et al. Severity of heroin dependence in Taiwan: reliability and validity of the Chinese version of the severity of dependence scale. Addict Behav. 2008;33(12).
Topp L, Mattick RP. Choosing a cut-off on the severity of dependence scale (SDS) for amphetamine users. Addiction. 1997;92(7):839–45.
pubmed: 9293043
Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53.
doi: 10.5116/ijme.4dfb.8dfd
pubmed: 28029643
pmcid: 4205511
Ware JE Jr, Gandek B. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. J Clin Epidemiol. 1998;51(11):945–52.
doi: 10.1016/S0895-4356(98)00085-7
pubmed: 9817111
Hoelter JW. The analysis of covariance structures: goodness-of-fit indices. Sociol Methods Res. 1983;11(3):325–44.
doi: 10.1177/0049124183011003003
Doll WJ, Xia W, Torkzadeh G. A confirmatory factor analysis of the end-user computing satisfaction instrument. MIS Q. 1994:453–61.
Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107(2):238.
doi: 10.1037/0033-2909.107.2.238
pubmed: 2320703
Hatcher L, O’Rourke N. A step-by-step approach to using SAS for factor analysis and structural equation modeling. SAS institute; 2013.
Comrey A, Lee H. A first course in factor analysis: psychology press. Taylor and Francis Group New York, NY; 2013.
Jones BT, Corbin W, Fromme K. A review of expectancy theory and alcohol consumption. Addiction. 2001;96(1):57–72.
doi: 10.1046/j.1360-0443.2001.961575.x
pubmed: 11177520
Leventhal AM, Schmitz JM. The role of drug use outcome expectancies in substance abuse risk: an interactional–transformational model. Addict Behav. 2006;31(11):2038–62.
doi: 10.1016/j.addbeh.2006.02.004
pubmed: 16616433
Newton TF, De La Garza R, Kalechstein AD, Tziortzis D, Jacobsen CA. Theories of addiction: methamphetamine users’ explanations for continuing drug use and relapse. Am J Addict. 2009;18(4):294–300.
doi: 10.1080/10550490902925920
pubmed: 19444733
pmcid: 3341929
Drummond DC. Theories of drug craving, ancient and modern. Addiction. 2001;96(1):33–46.
doi: 10.1046/j.1360-0443.2001.961333.x
pubmed: 11177518
Abdullah T, Brown TL. Mental illness stigma and ethnocultural beliefs, values, and norms: an integrative review. Clin Psychol Rev. 2011;31(6):934–48.
doi: 10.1016/j.cpr.2011.05.003
pubmed: 21683671
Ng CH. The stigma of mental illness in Asian cultures. Aust N Z J Psychiatry. 1997;31(3):382–90.
doi: 10.3109/00048679709073848
pubmed: 9226084
Fang SC, Hung CC, Huang CY, Huang SM, Shao JYH. Influence of Baseline Psychiatric disorders on mortality and suicide and their associations with gender and age in patients with Methamphetamine Use Disorder. Int J Mental Health Addict. 2023.